Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO : 1 (As of 2024-05-01)
Historical Data
Total 125
Basic Info
Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO was 1 as of 2024-05-01, according to GuruFocus. Historically, Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO reached a record high of 3 and a record low of 0.07, the median value is 0.4. Typical value range is from 0.07 to 1.08. The Year-Over-Year growth is 149.37%. GuruFocus provides the current actual value, an historical data chart and related indicators for Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO - last updated on 2024-05-01.
Monthly data, but the recent month data is updated daily. Note that the monthly insider buy/sell ratio for the current month is calculated based on insider buy/sell transactions within 30 days.
Category | Market Trend |
Region | USA |
Source | GuruFocus |
Stats
Name | Value | ||
---|---|---|---|
Last Value | 1 | ||
Latest Period | 2024-05-01 | ||
Long Term Average | 0.56 | ||
Average Annualized Growth Rate | 0% | ||
Value from 1 year ago | 0.4 | ||
Change from 1 year ago | +150% | ||
Frequency | Daily | ||
Unit |
Related Indicators
Discussions on Insider Buy/Sell Ratio - USA Drug Manufacturers, CFO
No discussions yet.